Search

everythinglearnresearchcommunity

for

Search:↓

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Deslorelin may help intact male dogs regrow hair from alopecia X, with a 75% success rate and no side effects.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

Melatonin, usually known for sleep regulation, also has antioxidant properties that can protect skin, stimulate hair growth, and improve skin conditions, with topical application being more effective than oral use.

Hair follicle stem cells are similar to bone marrow stem cells but are better for fat cell research.

MicroRNA-214 is important for skin and hair growth because it affects the Wnt pathway.

The consensus provided guidelines for treating the Female Athlete Triad and a system to decide when athletes can return to sports.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Combining cosmetic procedures with lifestyle changes improves antiaging results.

Dermatoscopy is a useful tool for diagnosing hair disorders and can help choose samples for more detailed analysis.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

New tools show that in fish, NPY increases feeding and somatostatin decreases it.

Low-level Laser Therapy may help reduce inflammation, pain, and aid healing, but more research is needed to confirm its effectiveness and establish standard treatment guidelines.

Homoeopathic treatment may help manage polycystic ovarian syndrome.

New therapies are being developed that target integrin pathways to treat various diseases.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Keratin-associated proteins have ancient origins and were used for different purposes before being adapted for hair in mammals.

Hair damage shows as fragility, dullness, and discoloration, varies by ethnicity, and is worsened by cosmetic procedures and diseases.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.